Cargando…
Characterization of a fusion protein of RGD4C and the β-lactamase variant for antibody-directed enzyme prodrug therapy
Antibody-directed enzyme prodrug therapy (ADEPT) delivers chemotherapeutic agents in high concentration to tumor tissue, while minimizing systemic drug exposure. ADEPT has been reported to be an attractive approach for improving the efficacy of cancer therapy. A previously reported β-lactamase was f...
Autores principales: | Zhou, Xiaoliang, Wang, Hao, Shi, Peiji, Meng, Ai-min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986274/ https://www.ncbi.nlm.nih.gov/pubmed/24748803 http://dx.doi.org/10.2147/OTT.S59346 |
Ejemplares similares
-
A Fusion Protein of RGD4C and β-Lactamase Has a Favorable Targeting Effect in Its Use in Antibody Directed Enzyme Prodrug Therapy
por: Wang, Hao, et al.
Publicado: (2015) -
Antibody directed enzymes revive anti-cancer prodrugs concept.
por: Bagshawe, K. D.
Publicado: (1987) -
Microbial cytosine deaminase is a programmable anticancer prodrug mediating enzyme: antibody, and gene directed enzyme prodrug therapy
por: El-Sayed, Ashraf S.A., et al.
Publicado: (2022) -
The biogenesis of β-lactamase enzymes
por: Kaderabkova, Nikol, et al.
Publicado: (2022) -
Prodrugs for Gene-Directed Enzyme-Prodrug Therapy (Suicide Gene Therapy)
por: Denny, William A
Publicado: (2003)